HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gupta, M. Articles by Bal, V. Search for Related Content PubMed PubMed Citation Articles by Gupta, M. Articles by Bal, V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Presence of Pentoxifylline During T Cell Priming Increases Clonal Frequencies in Secondary Proliferative Responses and Inhibits Apoptosis¹

Manisha Gupta^*, Anna George^*, Ranjan Sen, Satyajit Rath^*, Jeannine M. Durdik and Vineeta Bal^2,*

^* National Institute of Immunology, New Delhi, India; Rosenstiel Basic Medical Sciences Research Center and Department of Biology, Brandeis University, Waltham, MA 02254; and Department of Biological Sciences, University of Arkansas, Fayetteville, AR 72701

Naive T cells appear to be primed by specific Ag to differentiate into either effectors or memory cells. We have been analyzing the factors involved in this differential commitment in the priming of alloresponsive human T cells in vitro and have shown that the presence of a phosphodiesterase inhibitor, pentoxifylline (POX), during priming results in a decrease in the primary response and enhancement in the secondary proliferative response. We now show that the POX-mediated effect can be mimicked by dibutyryl cAMP. The secondary response enhancement is due to the effects of POX on the T cells rather than the APCs, because even fixed APCs can prime T cells in the presence of POX. POX affects T cells directly by increasing clonal frequency rather than the burst size of the secondary responders. The known inhibition of IL-2 production by POX is not responsible for this effect, because exogenous IL-2 supplementation does not block it. The presence of POX during priming alters the outcome of T cell activation, resulting in a lower frequency of cells expressing IL-2R (CD25) and a decrease in their subsequent apoptosis, and this anti-apoptotic effect is consistent with the enhanced commitment of T cells to secondary responsiveness by POX.

This article has been cited by other articles:

				M. Vig, A. George, R. Sen, J. Durdik, S. Rath, and V. Bal Commitment of Activated T Cells to Secondary Responsiveness Is Enhanced by Signals Mediated by cAMP-Dependent Protein Kinase A-I Mol. Pharmacol., December 1, 2002; 62(6): 1471 - 1481. [Abstract] [Full Text] [PDF]

				R. Suresh, M. Vig, S. Bhatia, E. P. B. Goodspeed, B. John, U. Kandpal, S. Srivastava, A. George, R. Sen, V. Bal, et al. Pentoxifylline Functions As an Adjuvant In Vivo to Enhance T Cell Immune Responses by Inhibiting Activation-Induced Death J. Immunol., October 15, 2002; 169(8): 4262 - 4272. [Abstract] [Full Text] [PDF]

				Y. Sun, L. Li, F. Lau, J. A. Beavo, and E. A. Clark Infection of CD4+ Memory T Cells by HIV-1 Requires Expression of Phosphodiesterase 4 J. Immunol., August 15, 2000; 165(4): 1755 - 1761. [Abstract] [Full Text] [PDF]